Tom Angell has been consistently ahead of the pack on all things related to marijuana news and politics – he’s had a great connection with lawmakers as well. Now he has a new email newsletter, currently titled “Generic Marijuana Newsletter.”
You can view it here and, if you wish, hit subscribe in the upper left corner (requires confirming a valid email address).
Obviously, everyone’s thinking and talking about what’s going to happen with drug policy with President Trump. It appears to me, that it’s going to take a bit of time to know for sure – things are so chaotic right now, with a lot of upheaval.
It’s interesting, though, seeing people try to predict. Check out this article in Business Insider: Don’t expect nationwide marijuana legalization under the Trump administration. Once you read the article, you realize that the author has no clue what will happen.
Of course, this is all up for change. If Trump’s attorney general appointee, Senator Jeff Sessions, is appointed, he could direct the DEA to take a more hardline stance. And if President Trump himself decides to take a more hardline stance, that would also impact how the DEA operates when it comes to federal marijuana policy. To be clear, neither Sessions nor Trump have indicated as much.
There’s been a lot of talk about “The Health Effects of Cannabis and Cannabinoids,” a report by the National Academy of Sciences that reviewed 10,000 scientific abstracts to actually get some consensus on the science of marijuana rather than the usual cherry-picking to prove a point. Coverage in Forbes.
Nick Jikomes at Leafly gives a fairly detailed overview of the report. Here’s What the National Academy’s Medical Cannabis Report Actually Says
If you want to read it yourself, you can download theentire pdf file here (simply log-in as a guest).
Personal note: I apologize if you’ve tried to reach me and haven’t gotten a response. I’m about 800 emails behind right now and working to get caught up.